healthcare

Deals ramp up in Asia’s healthcare space with cancer focus

An acquisition in Hong Kong by the New Frontier Group, an IPO by Sunho Biologics on the HKEX and a $1.5bn investment into Singapore by AstraZeneca, are signs that investments in next generation cancer treatments are increasing in the region.
May 28, 2024

Exploring the investible opportunity in life sciences & healthcare in the Asia Pacific region

Based on bespoke research with investors, professionals active in life sciences and healthcare, and advisors who help in the dealmaking process, as well as an in-depth study of recent trends in the space, the Life Sciences & Healthcare Report 2023 from FinanceAsia in partnership with DFIN offers a succinct and yet comprehensive overview of the investible opportunity in a critical sector.
DFIN

How BlackRock invests in the future of healthcare

Erin Xie, managing director and portfolio manager at BlackRock, explains the firm’s approach to capturing alpha across the various sub-sectors in this rapidly developing segment of the investment landscape.
March 23, 2021

Embracing a new wave of healthcare innovation

With healthcare destined to play an ever-greater role in everyday life, Ally Bridge Group founder and specialist life science investor Frank Yu tells FinanceAsia which sub-sectors to watch, and why.
March 02, 2021